• Contact
  • EPAD Academy
Top Bar Menu
TwitterFacebookYouTube
Search...
EPADEPAD
EPAD
European Prevention of Alzheimer's Dementia Consortium
  • Home
  • About
    • Welcome to EPAD
    • Project Objectives
    • Project Structure
    • EPAD Partners
    • Coordination & Management
    • EPAD Q&A
  • Our research
    • Participation in EPAD
      • Participation in EPAD Cohort
      • EPAD Study Visits
      • Trial Locations
      • Participation FAQs
    • The Participant’s Experience
      • The Research Participant Panel
      • EPAD Stories
    • The EPAD platform
      • The EPAD Platform
      • EPAD Benefits
      • Clinical Candidate Selection
      • EPAD FAQs
      • Research Resources
  • Open Access Data
    • Overview
    • Access
    • Data
    • MRI Images
  • Sample Access
  • News & Publications
    • Latest News
    • Newsletters
    • Publications
    • Videos
Menu back  

Interview with the fellows: Lisa Vermunt and Delia Gheorghe

2019-01-15EPAD Academy

Lisa Vermunt (VUmc) and Delia Gheorghe (UOXF), our young researchers, have presented EPAD at the IMI Scientific Symposium in October. Lisa and Delia were happy to answer some of our questions! Here’s a chance to get know them and their work a bit better.

What are your main tasks within the EPAD project?

LV: My main task involved setting up the EPAD Registry. In the beginning of the project, we created a small team, of which I am a member together with people from University of Leicester, Synapse and Pfizer. Everybody brought in different kinds of expertise. We also got local collaborators at the EPAD sites and the ‘parent cohorts’. After the Registry came into use, we continued to adapt and extend it. Currently, we are evaluating the scientific output of the EPAD Registry. That is exciting. Additionally, I contributed to data collection for the EPAD cohort by starting up the EPAD site in Amsterdam. I really enjoyed working with our participants. Their motivation for EPAD is inspiring. 

DG: Together with the CRO and the Oxford team, I provide local support for EPAD trial delivery centres across England and Wales in their delivery of the Longitudinal Cohort Study. My main objective is to encourage recruitment and engage EPAD centres with local cohorts.   

What are the advantages for a young researcher working on a distributed collaborative project such as EPAD?

LV: The advantages of working for an European project is that you get to work on cutting edge research and learn to deal with significant challenges. I have also had the chance to work with people in more than 8 different countries, which is both interesting and enjoyable. Yes, I can totally recommend it.

DG: It is a unique opportunity for an early career researcher to be involved in the coordination of such a complex project. Among the advantages of this role, I feel most strongly about the management skills and the network that I have the chance to develop. Such an experience may add significantly to the success of my future grant applications.

What are your expectations from the EPAD Academy?

DG: In this context, the EPAD Academy provides opportunities for early career researchers to develop a professional network and learn from experienced scientists. In addition, we are provided with the opportunity to make our work visible to both academic audiences and industry stakeholders.

Who do you look up to professionally?

LV: Aha, there are many people, as there are a lot of great investigators involved in EPAD! In particular, I am going to mention Gerald Luscan, because he is not well-known to everyone, but he has the capability to make every problem smaller.

Share this post
FacebookTwitterLinkedInGoogle+
Related posts
Two EPAD Fellows successfully defended their PhD thesis
2020-04-20
David Hague Early Career Investigator of the Year Award 2020
2019-06-07
9th Call for the 2020 European Young Researchers’ Award is now open
2019-05-23
Interview with Sammy Danso
2019-01-24
EPAD Academy Webinars
2019-01-15
The first EPAD Academy short exchange program has started
2018-09-24
Latest Academy News
  • Two EPAD Fellows successfully defended their PhD thesis
    2020-04-20
  • David Hague Early Career Investigator of the Year Award 2020
    2019-06-07
  • 9th Call for the 2020 European Young Researchers’ Award is now open
    2019-05-23
  • Interview with Sammy Danso
    2019-01-24
  • Interview with the fellows: Lisa Vermunt and Delia Gheorghe
    2019-01-15
What’s new

The EPAD Academy programme for short-term exchanges is ready to go. EASP is a short-term exchange programme, interdisciplinary and rotational, between the EPAD Consortium Partners, established and supported by the EPAD Academy. Interested? Write to us at academy@ep-ad.org.

Open vacancies

Alzheimer Europe is looking to fill two Luxembourg-based positions! For more info check their website.

Twitter
Twitter
EPAD
EPAD
@IMI_EPAD

📢@imi_epnd has launched its Cohort Catalogue, a central, open & accessible repository for researchers to discover studies & search metadata. Currently 67 research cohorts from 17 countries across Europe including @IMI_EPAD-VUmc participants ⬇️ eurekalert.org/news-releases/… twitter.com/imi_epnd/statu…

reply retweet favorite
9:56 am · 2023-03-14
Twitter
EPAD
EPAD
@IMI_EPAD

NEW paper published in @MetabolitesMDPI using LC-MS/MS method to determine salivary steroids using @IMI_EPAD samples. Congratulations @GregorySarah @zinghomer @guider50 @scottgdenham👏 @EdMassSpecCore @IMI2_NEURONET @IHIEurope #mdpimetabolites mdpi.com/2133518

reply retweet favorite
12:55 pm · 2023-03-02
Twitter
EPAD
EPAD
@IMI_EPAD

"There is a growing consensus that individual research results that are potentially relevant should be reported to research participants” & “Our work was positively received by the EPAD partners, and formed the basis for the set-up & the conduct of the study,” said Eline Bunnik

reply retweet favorite
10:32 am · 2023-01-31
Twitter
EPAD
EPAD
@IMI_EPAD

Have a look on the @IHIEurope newsletter including a spotlight on IMI results from projects on diabetes @HypoResolve and #Alzheimer’s disease @IMI_EPAD @IMI_AMYPAD ⬇️ Read it: bit.ly/3jeaxdM twitter.com/IHIEurope/stat…

reply retweet favorite
10:30 am · 2023-01-31
Twitter
EPAD
EPAD
@IMI_EPAD

17 centres have contributed to the @IMI_AMYPAD Prognostic Study across 11 Parent Cohorts including @IMI_EPAD. Have a look on the latest AMYPAD paper published in @FrontNeurol ⬇️ twitter.com/IMI_AMYPAD/sta…

reply retweet favorite
8:19 am · 2023-01-30
Copyright © 2015-2021 EPAD | Created by CMAST and Aridhia
  • Acronyms
  • Legal Notice
  • Privacy Policy
Bottom Menu

efpia-logo EU imi logo

This work has received support from the EU/EFPIA Innovative Medicines Initiative Joint Undertaking EPAD grant agreement nº 115736

This website uses cookies to improve your experience. Accept Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT